Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2018 1
2020 3
2021 3
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Smile! (Life will be better).
Esposito V, Sileno G, Abati S, Colucci M, Torreggiani M, Grosjean F, Esposito C. Esposito V, et al. Among authors: colucci m. J Nephrol. 2020 Aug;33(4):653-655. doi: 10.1007/s40620-020-00779-0. Epub 2020 Jun 17. J Nephrol. 2020. PMID: 32557242 Free PMC article. No abstract available.
…..and the kidney biopsy solved the puzzle.
Esposito V, Colucci M, Semeraro L, Esposito C. Esposito V, et al. Among authors: colucci m. J Nephrol. 2023 May;36(4):1189-1190. doi: 10.1007/s40620-022-01520-9. Epub 2022 Dec 15. J Nephrol. 2023. PMID: 36520367 Free PMC article. No abstract available.
Don't judge the book by its cover….
Pasquinucci E, Esposito V, Sileno G, Colucci M, Arazzi M, Esposito C. Pasquinucci E, et al. Among authors: colucci m. J Nephrol. 2021 Jun;34(3):913-914. doi: 10.1007/s40620-021-00980-9. Epub 2021 Mar 8. J Nephrol. 2021. PMID: 33683677 Free PMC article. No abstract available.
Petrus Leo: a contribution to the art of uroscopy.
Torreggiani M, Colucci M, Confalonieri CE, Esposito C. Torreggiani M, et al. Among authors: colucci m. J Nephrol. 2022 Mar;35(2):693-695. doi: 10.1007/s40620-021-01088-w. Epub 2021 Jun 17. J Nephrol. 2022. PMID: 34138455 Free PMC article. No abstract available.
13 results